NCT01797094 - BOTOX® in the Treatment of Upper Facial Lines in Japan | Biotech Hunter

Enrollment

101

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2014

Conditions

Upper Facial RhytidesCrow's Feet LinesGlabellar LinesFrown Lines

Interventions

BIOLOGICAL

botulinum toxin Type A (44U)

44 units botulinum toxin Type A (total dose) per treatment. 24 U injected into bilateral Crow's Feet Line areas and 20 U injected into Frown Line area.

BIOLOGICAL

botulinum toxin Type A (32U)

32 units botulinum toxin Type A (total dose) per treatment. 12 U injected into bilateral Crow's Feet Line areas and 20 U injected into Frown Line area.

Trial Locations (1)

Unknown

Tokyo